CN102041305B - 一种检测新生隐球菌的dna探针、基因芯片及其应用 - Google Patents
一种检测新生隐球菌的dna探针、基因芯片及其应用 Download PDFInfo
- Publication number
- CN102041305B CN102041305B CN2010102579754A CN201010257975A CN102041305B CN 102041305 B CN102041305 B CN 102041305B CN 2010102579754 A CN2010102579754 A CN 2010102579754A CN 201010257975 A CN201010257975 A CN 201010257975A CN 102041305 B CN102041305 B CN 102041305B
- Authority
- CN
- China
- Prior art keywords
- probe
- gene chip
- cryptococcus neoformans
- seq
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 43
- 108020003215 DNA Probes Proteins 0.000 title abstract 4
- 239000003298 DNA probe Substances 0.000 title abstract 4
- 239000000523 sample Substances 0.000 claims abstract description 77
- 238000001514 detection method Methods 0.000 claims abstract description 12
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 201000007336 Cryptococcosis Diseases 0.000 claims description 37
- 241000221204 Cryptococcus neoformans Species 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 27
- 239000012528 membrane Substances 0.000 claims description 25
- 239000004677 Nylon Substances 0.000 claims description 24
- 229920001778 nylon Polymers 0.000 claims description 24
- 230000003321 amplification Effects 0.000 claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 9
- 239000013641 positive control Substances 0.000 claims description 9
- 239000007790 solid phase Substances 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 6
- 239000002751 oligonucleotide probe Substances 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 5
- 239000013642 negative control Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000000020 Nitrocellulose Substances 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 239000005357 flat glass Substances 0.000 claims description 3
- 229920001220 nitrocellulos Polymers 0.000 claims description 3
- 239000002985 plastic film Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 21
- 102000053602 DNA Human genes 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 241000233866 Fungi Species 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 13
- 238000009396 hybridization Methods 0.000 description 12
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 11
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 206010007134 Candida infections Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 201000003984 candidiasis Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001225321 Aspergillus fumigatus Species 0.000 description 2
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000222173 Candida parapsilosis Species 0.000 description 2
- 241000222178 Candida tropicalis Species 0.000 description 2
- 241001527609 Cryptococcus Species 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000222175 Diutina rugosa Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108700005088 Fungal Genes Proteins 0.000 description 2
- 244000285963 Kluyveromyces fragilis Species 0.000 description 2
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 2
- 241000144128 Lichtheimia corymbifera Species 0.000 description 2
- 241001363490 Monilia Species 0.000 description 2
- 241000235645 Pichia kudriavzevii Species 0.000 description 2
- 241000235525 Rhizomucor pusillus Species 0.000 description 2
- 241000593344 Rhizopus microsporus Species 0.000 description 2
- 240000005384 Rhizopus oryzae Species 0.000 description 2
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 2
- 241001634961 Trichosporon asahii Species 0.000 description 2
- 241000222126 [Candida] glabrata Species 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229940091771 aspergillus fumigatus Drugs 0.000 description 2
- 208000032343 candida glabrata infection Diseases 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228232 Aspergillus tubingensis Species 0.000 description 1
- 241000228405 Blastomyces dermatitidis Species 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241001149962 Sporothrix Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- -1 antibody Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940055022 candida parapsilosis Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 108010056929 lyticase Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102579754A CN102041305B (zh) | 2010-08-18 | 2010-08-18 | 一种检测新生隐球菌的dna探针、基因芯片及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102579754A CN102041305B (zh) | 2010-08-18 | 2010-08-18 | 一种检测新生隐球菌的dna探针、基因芯片及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102041305A CN102041305A (zh) | 2011-05-04 |
CN102041305B true CN102041305B (zh) | 2012-08-08 |
Family
ID=43907853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102579754A Active CN102041305B (zh) | 2010-08-18 | 2010-08-18 | 一种检测新生隐球菌的dna探针、基因芯片及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102041305B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106893782B (zh) * | 2017-03-21 | 2019-08-27 | 中国人民解放军总医院 | 一种检测并鉴定隐球菌的靶基因、引物和探针及试剂盒 |
CN108060263B (zh) * | 2018-02-10 | 2020-03-06 | 杭州缔蓝生物技术有限公司 | 一种同时检测三种隐球菌的引物探针组合和荧光定量pcr试剂盒 |
CN111690760A (zh) * | 2020-03-10 | 2020-09-22 | 首都医科大学附属北京世纪坛医院 | 一种准确检测新生隐球菌的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286989C (zh) * | 2005-04-22 | 2006-11-29 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | 检测致病真菌生物芯片 |
-
2010
- 2010-08-18 CN CN2010102579754A patent/CN102041305B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286989C (zh) * | 2005-04-22 | 2006-11-29 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | 检测致病真菌生物芯片 |
Non-Patent Citations (1)
Title |
---|
程鹏飞 等.实时荧光定量PCR检测新生隐球菌DNA方法的建立.《武汉大学学报(理学版)》.2010,第56卷(第3期),343-347. * |
Also Published As
Publication number | Publication date |
---|---|
CN102041305A (zh) | 2011-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5196863B2 (ja) | プローブセット、プローブ担体及び検査方法 | |
JP2008278845A (ja) | プローブ、プローブセット、プローブ担体及び検査方法 | |
CN102041306B (zh) | 一种检测烟曲霉的dna探针、基因芯片及其应用 | |
CN102041305B (zh) | 一种检测新生隐球菌的dna探针、基因芯片及其应用 | |
CN103119163A (zh) | 小rna的获得方法 | |
CN102031300B (zh) | 一种检测土曲霉的dna探针、基因芯片及其应用 | |
CN104263833A (zh) | 用于念珠菌菌种鉴定和基因突变检测的核酸膜条和试剂盒 | |
CN102041308B (zh) | 一种检测光滑念珠菌的dna探针、基因芯片及其应用 | |
CN102041304B (zh) | 一种检测伞状犁头霉的dna探针、基因芯片及其应用 | |
CN102031289B (zh) | 一种检测近平滑念珠菌的dna探针、基因芯片及其应用 | |
CN102031299B (zh) | 一种检测黑曲霉的dna探针、基因芯片及其应用 | |
CN102031296B (zh) | 一种检测构巢曲霉的dna探针、基因芯片及其应用 | |
CN101638688A (zh) | 鉴定致病性念珠菌的专用探针与基因芯片 | |
CN102031295B (zh) | 一种检测小孢根霉的dna探针、基因芯片及其应用 | |
CN102041307B (zh) | 一种检测黄曲霉的dna探针、基因芯片及其应用 | |
CN102041309B (zh) | 一种检测少根根霉的dna探针、基因芯片及其应用 | |
CN102031291B (zh) | 一种检测都柏林念珠菌的dna探针、基因芯片及其应用 | |
CN102031293B (zh) | 一种检测皱褶念珠菌的dna探针、基因芯片及其应用 | |
CN102031298B (zh) | 一种检测微小根毛霉的dna探针、基因芯片及其应用 | |
CN102031297B (zh) | 一种检测乳酒念珠菌的dna探针、基因芯片及其应用 | |
CN102031294B (zh) | 一种检测阿萨希毛孢子菌的dna探针、基因芯片及其应用 | |
CN102031290B (zh) | 一种检测季也蒙念珠菌的dna探针、基因芯片及其应用 | |
CN102031292A (zh) | 一种检测克柔念珠菌的dna探针、基因芯片及其应用 | |
CN102031287A (zh) | 一种检测白念珠菌的dna探针、基因芯片及其应用 | |
CN102031288A (zh) | 一种检测热带念珠菌的dna探针、基因芯片及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160225 Address after: 100085 C, block 9, 3rd Street, Beijing, Haidian District, C301-52 Patentee after: Beijing Tianjian Wellcome Biotechnology Co. Ltd. Address before: 025150 the Inner Mongolia Autonomous Region Daban Town, Chifeng City cable bauges GA Ann brought a building plot 3-401 Patentee before: Li Guohui |
|
CP03 | Change of name, title or address |
Address after: Room 310, 44 Block No. 13, North Second Article, Zhongguancun, Haidian District, Beijing, 100190 Patentee after: Beijing Xinyi Biotechnology Co., Ltd. Address before: 100085 C301-52, Block C, 9th Shangdi Third Street, Haidian District, Beijing Patentee before: Beijing Tianjian Wellcome Biotechnology Co. Ltd. |
|
CP03 | Change of name, title or address |